Bruker Corporation
Here’s whether Bruker Corporation (BRKR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive). Concerns: 50-day MA is falling (-3.94% over 10 days); RSI 83 — overbought, elevated pullback risk; 3-month momentum negative (-15.9%). Currently 27.6% off its 52-week high. Score: +0/7.
BRKR is in a confirmed uptrend, trading above both its 50-day ($37.64) and 200-day ($39.77) moving averages. With an RSI of 83.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +7.8% compares to +35.1% for SPY (trailed the market by 27.3%). The current 27.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.